X4 Pharmaceuticals, Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
XFOR chart
What traders are saying about $XFOR
Latest postsX4 Pharmaceuticals, Inc news
- X4 Pharmaceuticals stock: Chairman Adam Craig buys 4,600 shares of X4 Pharmaceuticals stock
ad-hoc-news.de ·
- X4 Pharmaceuticals, Inc. Estimates – NASDAQ:XFOR
TradingView ·
- X4 Pharmaceuticals (NasdaqCM:XFOR) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- XFOR Q3'26 Earnings: revenue estimate is 2.30M USD
TradingView ·
- X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
Yahoo Finance ·
- X4 Pharmaceuticals Secures Up to $150 Million in New Debt Financing From K2 HealthVentures
investorshub.advfn.com ·
- X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
Yahoo Finance ·
- X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Down 25.4% in 4 Weeks, Here's Why X4 Pharmaceuticals (XFOR) Looks Ripe for a Turnaround
Yahoo Finance ·
- X4 Pharmaceuticals (XFOR) Loses 20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Yahoo Finance ·
- X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference
Yahoo Finance ·
- X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting
Yahoo Finance ·
X4 Pharmaceuticals, Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $35.1M | $2.6M | $0 | $0 |
| Net income | -$79.2M | -$37.5M | -$101.2M | -$93.9M |
| Diluted EPS | $-1.87 | $-5.59 | $-17.07 | $-1.52 |
| Total assets (year end) | $290.5M | $146.4M | $147.3M | $155.6M |
| Cash and equivalents (year end) | $217.0M | $55.7M | $99.2M | $121.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About X4 Pharmaceuticals, Inc
- Ticker
- XFOR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1501697
- Former names
- Arsanis, Inc.
Frequently asked questions
What exchange is X4 Pharmaceuticals, Inc listed on?
X4 Pharmaceuticals, Inc trades on the Nasdaq under the ticker symbol XFOR.
What industry is X4 Pharmaceuticals, Inc in?
X4 Pharmaceuticals, Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is X4 Pharmaceuticals, Inc headquartered?
X4 Pharmaceuticals, Inc's business address on file with the SEC is in Boston, MA.
When does X4 Pharmaceuticals, Inc's fiscal year end?
X4 Pharmaceuticals, Inc's fiscal year ends on December 31.
How much revenue did X4 Pharmaceuticals, Inc report?
X4 Pharmaceuticals, Inc reported $35.1M in revenue for calendar year 2025, according to its SEC filings.